References
- Carrington MJ, Bird T, Levene CI. 1984. The inhibition of lysyl oxidase in vivo by isoniazid and its reversal by pyridoxal. Effect on collagen cross-linking in the chick embryo. Biochemical Journal 221:837–843.
- Chopra A, Shan L, Eckelman W, Leung K, Latterner M, Bryant SH, Menkens A. 2012. Molecular imaging and contrast agent database (MICAD): evolution and progress. Molecular Imaging and Biology 14:4–13.
- De Luca R, Boulvain M, Irion O, Berner M, Pfister RE. 2009. Incidence of early neonatal mortality and morbidity after late-preterm and term cesarean delivery. Pediatrics 123:e1064–e1071.
- Gemzell-Danielsson K, Lalitkumar S. 2008. Second trimester medical abortion with mifepristone–misoprostol and misoprostol alone: a review of methods and management. Reproductive Health Matters 16:162–172.
- Ghosh K, Indra N, Jagadeesan G. 2017. The ameliorating effect of Centella asiatica ethanolic extract on albino rats treated with isoniazid. Journal of Basic and Clinical Physiology and Pharmacology 28:67–77.
- Gray RH, Ferraz EM, Amorim MS, De Melo LF. 1991. Levels and determinants of early neonatal mortality in Natal, northeastern Brazil: results of a surveillance and case-control study. International Journal of Epidemiology 20:467–473.
- Guinn DA, Davies JK, Jones RO, Sullivan L, Wolf D. 2004. Labor induction in women with an unfavorable Bishop score: randomized controlled trial of intrauterine Foley catheter with concurrent oxytocin infusion versus Foley catheter with extra-amniotic saline infusion with concurrent oxytocin infusion. American Journal of Obstetrics and Gynecology 191:225–229.
- Haghighi L, Mohabatian B. 2015. Isonicotinic acid hydrazide (INH): a new agent for cervical ripening at term. Journal of Obstetrics and Gynaecology 35:251–254.
- Haghighi L, Najmi Z, Rokhgireh S, Moradi Y. 2020. Intravaginal isonicotinic acid hydrazide (INH) versus misoprostol for cervical ripening prior to hysteroscopy. Obstetrics & Gynecology Science 63:514–520.
- Laborde J, Deraeve C, Lecoq L, Sournia-Saquet A, Stigliani JL, Orena BS, et al. 2016. Synthesis, oxidation potential and anti-mycobacterial activity of isoniazid and analogues: insights into the molecular isoniazid activation mechanism. ChemistrySelect 1:172–179.
- Lin A, Kupferminc M, Dooley SL. 1995. A randomized trial of extra-amniotic saline infusion versus laminaria for cervical ripening. Obstetrics and Gynecology 86:545–549.
- Mahendroo M. 2012. Cervical remodeling in term and preterm birth: insights from an animal model. Reproduction 143:429–438.
- Ngai SW, Chan YM, Lam SW, Lao TT. 2000. Labour characteristics and uterine activity: misoprostol compared with oxytocin in women at term with prelabour rupture of the membranes. British Journal of Gynecology 107:222–227.
- Plaut MM, Schwartz ML, Lubarsky SL. 1999. Uterine rupture associated with the use of misoprostol in the gravid patient with a previous cesarean section. American Journal of Obstetrics and Gynecology 180:1535–1542.
- Quemard A, LaCave C, Laneelle G. 1991. Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrobial Agents and Chemotherapy 35:1035–1039.
- Reif P, Brezinka C, Fischer T, Husslein P, Lang U, Ramoni A, et al. 2016. Labour and childbirth after previous caesarean section: recommendations of the Austrian Society of Obstetrics and Gynaecology (OEGGG). Geburtshilfe Und Frauenheilkunde 76:1279–1286.
- Richardson DK, Gray JE, Gortmaker SL, Goldmann DA, Pursley DM, McCormick MC. 1998. Declining severity adjusted mortality: evidence of improving neonatal intensive care. Pediatrics 102:893–899.
- Rohilla M, Joshi B, Jain V, Kalra J, Prasad G. 2016. Multidrug-resistant tuberculosis during pregnancy: two case reports and review of the literature. Case Reports in Obstetrics and Gynecology 2016:1536281.
- Rouëssé J, de la Lande B, Bertheault-Cvitkovic F, Serin D, Graïc Y, Combe M, et al. 2006. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. International Journal of Radiation Oncology*Biology*Physics 64:1072–1080.
- Santra S, Chowdhury A, Bishnu D, Dhali G, Santra A. 2017. NOX4 dependent activation of hepatic stellate cells with conditioned medium derived from isoniazid treated hepatocytes: an in-vitro study. Journal of Hepatology 66:S395.
- Schroeder E, de Souza ON, Santos D, Blanchard J, Basso L. 2002. Drugs that inhibit mycolic acid biosynthesis in Mycobacterium tuberculosis. Current Pharmaceutical Biotechnology 3:197–225.
- Shirley M. 2018. Dinoprostone vaginal insert: a review in cervical ripening. Drugs 78:1615–1624.
- Surita FGdC, Cecatti JG, Kruppa F, Tedesco RP, Parpinelli MÂ. 2004. Cervical ripening methods for labor induction. Revista Brasileira de Saúde Materno Infantil 4:125–133.
- Timmins GS, Master S, Rusnak F, Deretic V. 2004. Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 48:3006–3009.
- Wing DA, Jones MM, Rahall A, Goodwin TM, Paul RH. 1995. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. American Journal of Obstetrics and Gynecology 172:1804–1810.